Commentary: Barriers to concordance with antidiabetic drugs - Cultural differences or human nature?

British Medical Journal

Volumn 330, Issue 7502, 2005, Pages 1250-

  Greenhalgh, Trisha ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Department of Primary Health Care ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT;

CULTURAL FACTOR; ETHNIC DIFFERENCE; HEALTH PROMOTION; HUMAN; INDIAN; LANGUAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PAKISTAN; POLICY; PRIORITY JOURNAL; SIDE EFFECT; UNITED KINGDOM; ATTITUDE TO HEALTH; CULTURAL ANTHROPOLOGY; ETHNOLOGY; INDIA; PERCEPTION; PSYCHOLOGICAL ASPECT;

ATTITUDE TO HEALTH; CULTURE; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INDIA; PAKISTAN; PERCEPTION;

EID: 20444481385     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38464.595741.AE     Document Type: Note

References (5)

1. Lawton J, Ahmad N, Hallowell N, Hanna L, Douglas M. Perceptions and experiences of taking oral hypoglycaemic agents among people of Pakistani and Indian origin: qualitative study. BMJ 2005;330:1247-9.
2. Marinker M, Blenkinsopp A, Bond C. From compliance to concordance: achieving shored goals in medicine taking. London: Royal Pharmaceutical Society of Great Britain, 1997.
3. Britten N, Stevenson F, Gafaranga J, Barry C, Bradley C. The expression of aversion to medicines in general practice consultations. Soc Sci Med 2004;59:1495-503.
4. Stevenson FA, Cox K, Britten N, Dundar Y. A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect 2004;7:235-45.
5. National Consumer Council. Health literacy-being able to make the most of health. London: National Consumer Council, 2004.